Moderna
MRNA
$102.00
Share price
-1.39%
Change (1 day)
-28.49%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Number of shares outstanding for Moderna (MRNA)
Number of shares outstanding as of April 2024 : 381,000,000
According to Moderna 's latest financial reports and stock price the company's current number of shares outstanding is 381,000,000. At the end of 2023 the company had 381,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Moderna from 2018 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.38 B | -1.04% |
| 2022 | 0.38 B | -4.94% |
| 2021 | 0.40 B | 2.09% |
| 2020 | 0.39 B | 18.63% |
| 2019 | 0.33 B | 1.7% |
| 2018 | 0.32 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 531.81% | 🇺🇸 USA |
 Novartis NVS | 2,062,000,000 | 441.21% | 🇨🇭 Switzerland |
 Merck MRK | 2,554,166,667 | 570.38% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | 19,628,815 | -94.85% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | 73,916,400 | -80.60% | 🇺🇸 USA |
 Athersys ATHX | 24,492,000 | -93.57% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | 125,220,000 | -67.13% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | 107,415,000 | -71.81% | 🇺🇸 USA |